1. Home
  2. QURE

QURE

uniQure N.V.

Logo uniQure N.V.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Founded: 1998 Country:
Netherlands
Netherlands
Employees: N/A City: AMSTERDAM
Market Cap: 248.8M IPO Year: 2007
Target Price: $29.22 AVG Volume (30 days): 1.0M
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -6.47 EPS Growth: N/A
52 Week Low/High: $4.76 - $22.48 Next Earning Date: 05-07-2024
Revenue: $15,843,000 Revenue Growth: -85.12%
Revenue Growth (this year): 226.36% Revenue Growth (next year): 67.20%

Share on Social Networks: